I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ravasio, Roberto
239
results:
Search for persons
X
Format
Online (239)
Mediatypes
Articles (Online) (83)
OpenAccess-fulltext (156)
Languages
english (187)
italian (1)
Sorted by: Relevance
Sorted by: Year
?
1
Economic evaluation of two therapeutic sequences in the fir..:
Armeni, Patrizio
;
Compagnucci, Elena
;
Fiorino, Gionata
...
AboutOpen. 11 (2024) 1 - p. 21-29 , 2024
Link:
https://doi.org/10.33393..
?
2
Caloric restriction leads to druggable LSD1-dependent cance..:
Pallavi, Rani
;
Gatti, Elena
;
Durfort, Tiphanie
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
3
Cost per NNT for upadacitinib in the treatment of patients ..:
Chiricozzi, Andrea
;
Costanzo, Antonio
;
Levi, Anna
..
Global and Regional Health Technology Assessment. 11 (2024) 1 - p. 38-50 , 2024
Link:
https://doi.org/10.33393..
?
4
Expert Insights from a Delphi-driven Neurologists' Panel: R..:
Lidonnici, Dario
;
Brambilla, Pietro
;
Ravasio, Roberto
...
Journal of Neuromuscular Diseases. 11 (2024) 2 - p. 411-423 , 2024
Link:
https://doi.org/10.3233/..
?
5
Cost per Number Needed to Treat (NNT) for upadacitinib in t..:
Caprioli, Flavio
;
Fantini, Massimo Claudio
;
Marando, Francesca
..
Global and Regional Health Technology Assessment. 11 (2024) 1 - p. 55-67 , 2024
Link:
https://doi.org/10.33393..
?
6
Budget impact analysis of natalizumab biosimilar on pharmac..:
Bergamaschi, Roberto
;
Capobianco, Marco
;
Ravasio, Roberto
AboutOpen. 11 (2024) 1 - p. 48-56 , 2024
Link:
https://doi.org/10.33393..
?
7
Cost per responder for vedolizumab and ustekinumab in Crohn..:
Ravasio, Roberto
;
Viti, Raffaella
;
Roscini, Antonio Saverio
AboutOpen. 10 (2023) - p. 13-21 , 2023
Link:
https://doi.org/10.33393..
?
8
Cost-minimization analysis of HYQVIA® in the treatment of p..:
Ravasio, Roberto
;
Ripoli, Silvia
AboutOpen. 10 (2023) - p. 69-77 , 2023
Link:
https://doi.org/10.33393..
?
9
A new cost-utility analysis assessing risk factor-guided pr..:
Keary, Ian P.
;
Ravasio, Roberto
;
Fullarton, John R.
...
PLOS ONE. 18 (2023) 8 - p. e0289828 , 2023
Link:
https://doi.org/10.1371/..
?
10
Erratum in: Cost per responder for upadacitinib vs abatacep..:
Caporali, Roberto
;
Ravasio, Roberto
;
Raimondo, Paola
.
Global & Regional Health Technology Assessment. 9 (2022) - p. 30 , 2022
Link:
https://doi.org/10.33393..
?
11
Treatment management of patients with systemic lupus erythe..:
Sebastiani, Gian Domenico
;
Mosca, Marta
;
Ravasio, Roberto
...
Global & Regional Health Technology Assessment. 9 (2022) - p. 123-132 , 2022
Link:
https://doi.org/10.33393..
?
12
Cost-utility analysis of brigatinib compared to alectinib i..:
Ravasio, Roberto
;
Cranmer, Holly
;
Kearns, Izzie
..
AboutOpen. 9 (2022) - p. 92-104 , 2022
Link:
https://doi.org/10.33393..
?
13
The costs incurred by patients to get eligibility to PCSK9 ..:
Bertolani, Arianna
;
Ravasio, Roberto
;
Raimondo, Paola
.
Global & Regional Health Technology Assessment. 9 (2022) - p. 73-81 , 2022
Link:
https://doi.org/10.33393..
?
14
Cost per responder for upadacitinib vs abatacept in patient..:
Caporali, Roberto
;
Ravasio, Roberto
;
Raimondo, Paola
.
Global & Regional Health Technology Assessment. 8 (2021) - p. 69-79 , 2021
Link:
https://doi.org/10.33393..
?
15
Number needed to treat for interleukin inhibitors approved ..:
Ravasio, Roberto
;
Costanzo, Antonio
;
Antonelli, Silvia
..
Global & Regional Health Technology Assessment. 8 (2021) - p. 53-57 , 2021
Link:
https://doi.org/10.33393..
1-15